Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-024033

PRESIDENT AND CEO sold 23,125 shares at an average $46.05 ($1,064,809)

  • PRESIDENT AND CEO acquired 23,125 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · PRESIDENT AND CEO

Table I: Non-derivative

22 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-25 Exercise or conversion : show line 1 in the form 10b5-1 +8,643 $2.90 $25,037 316,615 D
2024-09-25 Sale : show line 2 in the form 10b5-1 −8,643 $45.43 $392,608 307,972 D
2024-09-25 Exercise or conversion : show line 3 in the form 10b5-1 +4,817 $2.90 $13,954 312,789 D
2024-09-25 Sale : show line 4 in the form 10b5-1 −4,817 $46.62 $224,588 307,972 D
2024-09-25 Exercise or conversion : show line 5 in the form 10b5-1 +2,165 $2.90 $6,272 310,137 D
2024-09-25 Sale : show line 6 in the form 10b5-1 −2,165 $47.06 $101,883 307,972 D
2024-09-25 Exercise or conversion : show line 7 in the form 10b5-1 +975 $2.90 $2,824 308,947 D
2024-09-25 Sale : show line 8 in the form 10b5-1 −975 $45.48 $44,342 307,972 D
Open-market sales · 23,125 sh · avg $46.05 · $1,064,809

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2024-09-25 Exercise or conversion : show line 23 in the form 10b5-1 Stock Option (Right to Buy) −15,625 811,712 D
2024-09-25 Exercise or conversion : show line 24 in the form 10b5-1 Stock Option (Right to Buy) −1,875 809,837 D
2024-09-25 Exercise or conversion : show line 25 in the form 10b5-1 Stock Option (Right to Buy) −1,875 807,962 D
2024-09-25 Exercise or conversion : show line 26 in the form 10b5-1 Stock Option (Right to Buy) −1,875 806,087 D
2024-09-25 Exercise or conversion : show line 27 in the form 10b5-1 Stock Option (Right to Buy) −1,875 804,212 D
Loading xslF345X05/form4-09272024_080904.xml…